Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - RESEARCH & DEVELOPMENT
Research & Development ANVS - Annovis Bio, Inc.
38.8 M
LAST VALUE
113.89%
2 YEAR CAGR
222.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR